Navigation Links
Shameful Votes Today on Children's Health Care by Reps. John Peterson, Joe Pitts and Bill Shuster
Date:10/18/2007

HARRISBURG, Pa., Oct. 18 /PRNewswire-USNewswire/ --Pennsylvania AFL-CIO President William George expressed his appreciation to the 16 members of Pennsylvania's U.S. House Delegation who voted in favor of overriding President Bush's veto of H.R. 976, the Children's Health Insurance Program Act of 2007. President George also voiced disappointment with the three Republican House members from Pennsylvania who supported the President's veto, against providing health insurance for the growing number of uninsured children of working families in Pennsylvania and the nation.

"It is hard to fathom why anyone would vote for President Bush's veto of children's health insurance -- and Representatives John Peterson, Joe Pitts, and Bill Shuster's decision to not override that veto -- is just plain shameful," Pennsylvania AFL-CIO President Bill George stated.

"In the richest country in the world, nearly 10 million kids have no health insurance. That is disgraceful. Our health care system is clearly broken," George said.

"The cost of health insurance premiums is rising at nearly twice the size of the average worker's paycheck. Businesses are throwing up their hands and saying they can't afford to cover any of their employees anymore. Already there are 301,000 children in Pennsylvania who don't have health insurance," he said.

"The State Children's Health Insurance Program has been one of the few bright spots in this health care picture. If the compromise bill passed 178,000 kids in our state would have health insurance. That's why the compromise bill passed by the House and Senate got substantial Republican as well as Democratic support," George said.

"The President's veto represents an extreme position. At a time when the President is asking for $200 billion dollars to keep funding his failed war in Iraq, it is hard to understand why he wouldn't support spending $35 billion over six years for something that actually works," George said. '/>"/>

SOURCE Pennsylvania AFL-CIO
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Light therapy devotes new hope in advanced lung cancer
2. US Senate Votes against Testing of Pesticide on Humans
3. U.S President Defied-Senate Votes To Expand Child Health Insurance
4. Results Of Human Trials Of Hungarian Bird-Flu Vaccine Expected Today
5. The older generation today, better off then predecessors.
6. Oral Sex and Anal Sex More Common in Teens Today
7. Minor Fire At AIIMS In The Wee Hours Today
8. New Delhi Hosting An Asian Delegation On bird Flu From Today
9. Anabolic Steroids for Today’s Young Me
10. Synova Acquires Rights to Today Sponge Contraceptive, Plans Advertising Campaign
11. Today’s Teens Slacking on Fruit, Veggie Intak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... PA (PRWEB) July 29, 2014 ... the Sewickley and Moon Township areas, has affiliated with ... Women’s Health will continue to deliver babies and perform ... need of advanced care will be referred to Allegheny ... are proud to be associated with West Penn Hospital ...
(Date:7/29/2014)... Representatives with BNatrl announced today that ... BNatrl Silver Solution 12ppm . , “It’s safe for ... BNatrl LLC. “It helps boost your immune system and ... and microbes.” , BNatrl develops and manufactures organic food ... 10 percent of profits being used to fund projects ...
(Date:7/29/2014)... 2014 Regents Health Resources, a consulting ... brought health care industry veteran Daryl Demonbreun and former ... lead the company’s ambitious plans to grow into a ... been moving along at a steady pace for nearly ... a notch,” says Bob Maier, founder and chief executive ...
(Date:7/29/2014)... According to the new market research report, "Fingerprint ... (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), Application (Mobile ... & Finance), and Geography - Global Trends & ... the global Fingerprint Sensors Market is projected to ... high CAGR of 16.8% from 2014 to 2020. ...
(Date:7/29/2014)... This Latest Guidebook for Conducting Pharma ... Edition) not only provided a comprehensive and thorough knowledge ... imported drug registration but also introduced the practical operation ... you to use the Chinese trial venues to keep ... step by step. , The audiences of this guidebook ...
Breaking Medicine News(10 mins):Health News:Leading West Suburban OBGYN Practice, Premier Women’s Health, Joins Allegheny Health Network 2Health News:Leading West Suburban OBGYN Practice, Premier Women’s Health, Joins Allegheny Health Network 3Health News:BNatrl Launches New Silver Solution Product 2Health News:Sferrella and Demonbruen Join Regents Health Resources 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4
... Reporter , WEDNESDAY, July 20 (HealthDay News) -- Some ... unexplained breathing problems that may be related to exposure ... disorders are emerging as a major consequence of service ... King, an assistant professor of pulmonary and critical care ...
... By Maureen Salamon HealthDay Reporter , ... both cause red, scaly skin rashes, but the similarities ... And now, examining patients suffering from both ... out the opposing immune system responses that prompt skin ...
... scientists have developed a gene-based test to distinguish harmless ... help some patients avoid needless surgery to remove the ... published in the July 20 issue of Science ... cysts are identified in more than a million patients ...
... July 20 (HealthDay News) -- The number of surgical errors ... study finds. In reviewing adverse events and close calls ... in the July 15 issue of the Archives of ... greater emphasis on safety, as well as improved training and ...
... Nev. Caffeine reduces muscle activity in the Fallopian tubes ... "Our experiments were conducted in mice, but this finding goes ... reduce a woman,s chance of becoming pregnant," says Sean Ward, ... Nevada School of Medicine, who conducted the study. ...
... The American Society for Radiation Oncology (ASTRO) has ... Junior Faculty Career Research Training Award and the ... Winners were selected by ASTRO,s Research Evaluation Committee. ... is awarded to stimulate interest in radiation research ...
Cached Medicine News:Health News:Breathing Problems Strike Soldiers Returning From Iraq 2Health News:Scientists Close in on Origins of Psoriasis, Eczema 2Health News:Scientists Close in on Origins of Psoriasis, Eczema 3Health News:Benign or cancerous? Gene test predicts cancer potential in pancreatic cysts 2Health News:Benign or cancerous? Gene test predicts cancer potential in pancreatic cysts 3Health News:Fewer Surgical Errors Reported at VA Medical Facilities 2Health News:Nevada School of Medicine researcher finds caffeine consumption, female infertility link 2
(Date:7/29/2014)... and TORONTO ... Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical ... development of improved novel formulations and alternative ... announces expansion of its pharmaceutical development implementing ... direction includes large molecule drugs that will address ...
(Date:7/29/2014)... , July 29, 2014  Based on ... systems (PERS) market, Frost & Sullivan recognizes MobileHelp ... Award for Price Performance Value Leadership. MobileHelp,s leadership ... captures expectations for tech progression in personal emergency ... for these solutions. MobileHelp is at ...
(Date:7/29/2014)... Medical Corporation (Apex, TWSE: 4106), a leading player in the ... is appealing the judgment of the Regional Court of ... that found the headgear of certain mask models infringe a ... against various ResMed patents in major countries. Apex further reiterates ... ResMed filed the lawsuit with the Regional ...
Breaking Medicine Technology:EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 4Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market 2Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market 3Apex Continues Fighting Against Patents to Free Up Competition 2
... 2011 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... and commercialization of products for central nervous system disorders, ... one of Israel,s leading private biotech, pharmaceutical and medical ... Israel. "We are excited to reach this ...
... Cell Therapeutics, Inc. ("CTI") (NASDAQ: CTIC ... that final results from the phase II OPAL study ... acute myeloid leukemia (AML) were presented by Jorge Cortes, ... Center during the Acute Myeloid Leukemia - Therapy, excluding ...
Cached Medicine Technology:Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 2Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 3Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel 4Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML) 2Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML) 3Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML) 4
... and removal in the urinary tract. The nitinol ... shape following extreme torsion. The unique tipless design ... basket to open at the base of the ... reduces the likelihood of mucosal damage and perforation. ...
... Used for soft-tissue ... limited to paravaginal repairs, ... or rectocele. Surgisis® ES ... enhanced strength for intraoperative ...
... Used for temporary suprapubic urinary diversion ... puncture the bladder. The access sheath is ... Once the catheter is introduced, the access ... low-profile catheter support is included for external ...
... and a FAM-labeled probe targeting the VP1 gene ... ASR contains primers and a Texas Red-labeled probe ... an instrument that can detect FAM and Texas ... Analyte Specific Reagent* (ASR) program is comprised of ...
Medicine Products: